The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 06, 2018

Filed:

Dec. 05, 2014
Applicant:

Canbex Therapeutics Limited, London, Greater London, GB;

Inventor:

David Selwood, Hertfordshire, GB;

Assignee:

CANBEX THERAPEUTICS LIMITED, London, Greater London, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 233/83 (2006.01); C07C 231/12 (2006.01); C07C 303/40 (2006.01); C07C 311/46 (2006.01); C07D 207/06 (2006.01); C07C 311/06 (2006.01); C07C 311/13 (2006.01); C07C 233/87 (2006.01); C07C 255/41 (2006.01); C07D 213/64 (2006.01); C07D 295/10 (2006.01); C07C 253/30 (2006.01); C07D 211/16 (2006.01); C07D 277/30 (2006.01);
U.S. Cl.
CPC ...
C07C 233/83 (2013.01); C07C 231/12 (2013.01); C07C 233/87 (2013.01); C07C 253/30 (2013.01); C07C 255/41 (2013.01); C07C 303/40 (2013.01); C07C 311/06 (2013.01); C07C 311/13 (2013.01); C07C 311/46 (2013.01); C07D 207/06 (2013.01); C07D 211/16 (2013.01); C07D 213/64 (2013.01); C07D 277/30 (2013.01); C07D 295/10 (2013.01);
Abstract

The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt thereof: (I) wherein: n is 0 or 1; R1 is selected from H, alkyl and aralkyl, wherein said alkyl and aralkyl groups may be optionally substituted by one or more OH groups; X is a group selected from —C≡C—(CH)—; —C(R)═C(R)—(CH)—; and —C(R)(R)C(R)(R)—(CH)r-; where each of R, R, Rand Ris independently H or alkyl, and each of p, q and r is independently 1, 2, 3, 4 or 5; Y is a group selected from: CN; COOR; CONRR; SONRR; NRCOR; NRSOR; and a heterocyclic group selected from oxadiazolyl, thiazolyl, iso-thiazolyl, oxazolyl, iso-oxazolyl, pyrazolyl and imidazolyl; where each of R, Rand Ris independently H or alkyl; or Rand Rare linked, together with the nitrogen to which they are attached, to form a 5 or 6-membered heterocycloalkyl or heterocycloalkenyl group, said heterocycloalkyl or heterocycloalkenyl group optionally containing one or more further groups selected from O, N, CO and S, and where each of R, R, R, R, R, Rand Ris independently H or alkyl. Further aspects of the invention relate to the use of such compounds in the preparation of a medicament for the treatment of a muscular disorder, pain, or for controlling spasticity or tremors, for example, spasticity in MS.


Find Patent Forward Citations

Loading…